PfizerBioNTech

UPDATED: BioNTech, Pfizer say test shows 3 doses of vaccine neutralise Omicron

BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test and they could deliver an…

Read More Here

Pfizer submits data for COVID-19 vaccine use in younger kids

Pfizer Inc and BioNTech SE submitted initial trial data for their COVID-19 vaccine in 5-11 year olds and said they would make a formal request to U.S. regulators for emergency…

Read More Here

Heart inflammation risk boosted slightly by vaccine, more by COVID-19 – study

The use of Pfizer Inc and German partner BioNTech SE’s widely used COVID-19 vaccine marginally increases the risk of heart inflammation, but the risk is higher among those infected with…

Read More Here

Pfizer, BioNTech to deliver 60 mln more COVID-19 vaccine doses to Turkey

U.S. drugmaker Pfizer Inc and its German partner BioNTech SE said on Thursday they would supply Turkey with 60 million additional doses of their COVID-19 vaccine. The latest agreement includes…

Read More Here

Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

Pfizer Inc and partner BioNTech SE said on Friday they had applied to the European health regulator to extend the marketing authorization for their coronavirus vaccine for use in adolescents…

Read More Here

Israel sees some vaccine efficacy against Indian COVID-19 variant

Israel has registered eight cases of a coronavirus variant first identified in India and believes that the Pfizer/BioNTech vaccine is at least partially effective against it, an Israeli health official…

Read More Here

Pfizer COVID-19 shot 91% effective in updated data, protective against South African variant

Pfizer Inc and BioNTech said on Thursday their COVID-19 vaccine is around 91% effective at preventing the disease, citing updated trial data that included participants inoculated for up to six…

Read More Here

Pfizer says South African variant could significantly reduce vaccine protection

A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if…

Read More Here

8.5% of US population gets Covid jab

The US Center for Disease Control and Prevention said it had administered 35,203,710 doses of COVID-19 vaccines in the country as of Thursday while 57,489,675 doses were distributed. This includes…

Read More Here

Pfizer cuts vaccine deliveries by as much as half to some EU countries

Pfizer has slashed in half the volume of COVID-19 vaccines it will deliver to some EU countries this week, government officials said, as frustration over the U.S. drugmaker’s unexpected cut…

Read More Here

UPDATED: Pfizer vaccine appears effective against coronavirus variant found in Britain

The COVID-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, which was discovered in Britain and has spread around the…

Read More Here

EU states warn of risks to vaccination credibility as Pfizer slows supplies

European governments said the credibility of their COVID-19 vaccination programmes was at risk on Friday after U.S. pharmaceutical firm Pfizer announced a temporary slowdown of deliveries of its vaccines. Shots…

Read More Here

UPDATED: Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants

Pfizer Inc and BioNTech's COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in Britain and South Africa, according to…

Read More Here